A Platform for Hacking into the Brain: A new Paradigm for Data Driven Neurodiagnostics - Speaker: Dr. Philip Low, world-renowned neuroscientist/entrepreneur/creator of the iBrain
Date and Time
Thursday December 01, 12:00pm to 1:00pm
Location
Gunn 101, Knight Management Center
Host
AdminYasemin Denari
Co-President
Details
Want to hold a human brain in your hands or just learn how it works from one of the world's top neuroscientists? You can do both at this BBL - you don't want to miss it!!
About the speaker:
Philip Low, PhD
Founder, Chairman & CEO, NeuroVigil, Inc.
Adjunct Professor, Stanford School of Medicine
Research Affiliate, MIT Media Lab
WINNER, KAVLI Brain and Mind Innovative Research award
WINNER, Draper Fisher Jurvetson Venture Challenge
WINNER, UCSD Entrepreneurship Competition
WINNER, CONNECT Most Innovative New Product
MIT TR-35, Top Young Innovator, Worldwide
TOP 10 Most Innovative Companies in Health Care, Worldwide
WINNER, Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship
Philip Low is Chairman and Chief Executive Officer of NeuroVigil, the award-winning wireless neurodiagnostics company headquartered in San Diego, CA. At the University of Chicago, he invented novel neurosurgical techniques. At Harvard Medical School, he showed in 9 weeks that a collagen inhibitor could successfully neutralize the growth of fibroid tumors – he was 19 years old at the time. At the Salk Institute, he invented the SPEARS algorithm and authored a single page PhD thesis, a solution to a longstanding problem in brainwave analysis, which was unanimously approved by a committee including four members of the National Academy of Sciences and two past Presidents of the Society for Neuroscience (the degree was officially granted by UCSD, which had tried to flunk him out of the PhD program five years prior). Dr. Low holds dual appointments at the Stanford School of Medicine and the MIT Media Lab, as well as an extraordinary ability recognition in the field of brain signal detection from the United States Government. He was named President of the 1st International Congress on Alzheimer’s Disease and Advanced Neurotechnologies, held in Monaco in February 2010 and chairs the Francis Crick Memorial Conference on Consciousness, to be held in Cambridge, UK, in July 2012. Dr. Low’s work has been featured in technical and popular articles and segments including CNN, NBC, TEDMED, The Economist, Forbes, The New York Times and the Proceedings of the National Academy of Sciences, USA. To bring his innovations to the market, Dr. Low founded NeuroVigil when he was a graduate student and enlisted four Nobel Laureates and three Fortune 100 company founders. Under Dr. Low’s leadership, NeuroVigil won the 2008 UCSD Entrepreneur Challenge, the 2008 DFJ Venture Challenge, the 2010 CONNECT Most Innovative New Product Award for iBrainTM, a wireless iPod for the brain, used since 2009 by some of the world’s top pharmaceutical companies with outpatient drug evaluations, and was listed by Fast Company and The Washington Post as one of the Top 10 Most Innovative Companies in Health Care in 2011, along with GE and the Cleveland Clinic. For his innovative contributions to Biomedicine as well as for his business leadership, Dr. Low has been recognized by the MIT Technology Review as one of the 35 top innovators under 35 worldwide (past recipients include the founders of Linux, Netscape, Paypal, Google and Facebook). On May 1st 2011, NeuroVigil successfully completed one of the largest seed valuation financings to-date. The same year, Dr. Low became the first recipient of the inaugural Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship, awarded once every five years, irrespectively of age, gender or geographical location, to an extraordinary scientist and chief executive for combined disruptive leadership in technology and business.
About the speaker:
Philip Low, PhD
Founder, Chairman & CEO, NeuroVigil, Inc.
Adjunct Professor, Stanford School of Medicine
Research Affiliate, MIT Media Lab
WINNER, KAVLI Brain and Mind Innovative Research award
WINNER, Draper Fisher Jurvetson Venture Challenge
WINNER, UCSD Entrepreneurship Competition
WINNER, CONNECT Most Innovative New Product
MIT TR-35, Top Young Innovator, Worldwide
TOP 10 Most Innovative Companies in Health Care, Worldwide
WINNER, Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship
Philip Low is Chairman and Chief Executive Officer of NeuroVigil, the award-winning wireless neurodiagnostics company headquartered in San Diego, CA. At the University of Chicago, he invented novel neurosurgical techniques. At Harvard Medical School, he showed in 9 weeks that a collagen inhibitor could successfully neutralize the growth of fibroid tumors – he was 19 years old at the time. At the Salk Institute, he invented the SPEARS algorithm and authored a single page PhD thesis, a solution to a longstanding problem in brainwave analysis, which was unanimously approved by a committee including four members of the National Academy of Sciences and two past Presidents of the Society for Neuroscience (the degree was officially granted by UCSD, which had tried to flunk him out of the PhD program five years prior). Dr. Low holds dual appointments at the Stanford School of Medicine and the MIT Media Lab, as well as an extraordinary ability recognition in the field of brain signal detection from the United States Government. He was named President of the 1st International Congress on Alzheimer’s Disease and Advanced Neurotechnologies, held in Monaco in February 2010 and chairs the Francis Crick Memorial Conference on Consciousness, to be held in Cambridge, UK, in July 2012. Dr. Low’s work has been featured in technical and popular articles and segments including CNN, NBC, TEDMED, The Economist, Forbes, The New York Times and the Proceedings of the National Academy of Sciences, USA. To bring his innovations to the market, Dr. Low founded NeuroVigil when he was a graduate student and enlisted four Nobel Laureates and three Fortune 100 company founders. Under Dr. Low’s leadership, NeuroVigil won the 2008 UCSD Entrepreneur Challenge, the 2008 DFJ Venture Challenge, the 2010 CONNECT Most Innovative New Product Award for iBrainTM, a wireless iPod for the brain, used since 2009 by some of the world’s top pharmaceutical companies with outpatient drug evaluations, and was listed by Fast Company and The Washington Post as one of the Top 10 Most Innovative Companies in Health Care in 2011, along with GE and the Cleveland Clinic. For his innovative contributions to Biomedicine as well as for his business leadership, Dr. Low has been recognized by the MIT Technology Review as one of the 35 top innovators under 35 worldwide (past recipients include the founders of Linux, Netscape, Paypal, Google and Facebook). On May 1st 2011, NeuroVigil successfully completed one of the largest seed valuation financings to-date. The same year, Dr. Low became the first recipient of the inaugural Jacobs-Rady Pioneer Award for Global Innovation and Entrepreneurship, awarded once every five years, irrespectively of age, gender or geographical location, to an extraordinary scientist and chief executive for combined disruptive leadership in technology and business.
Login to RSVP.
